Interstitial pneumonitis secondary to intravesical bacillus calmette-guerin for carcinoma in-situ of the bladder

Interstitial pneumonitis secondary to intravesical bacillus calmette-guerin for carcinoma in-situ of the bladder

We report an 81-year-old male who developed severe interstitial pneumonitis on maintenance intravesical Bacillus Calmette-Guerin (BCG) for in-situ carcinoma of the bladder. The patient was treated with steroids and anti-tuberculin therapy with complete response. While there is no established standar...

Full description

Bibliographic Details
Main Authors:	Eric K. Diner, Mohan Verghese
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Urologia 2004-10-01
Series:	International Brazilian Journal of Urology
Subjects:	bladder neoplasms BCG intravesical injection pneumonitis
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382004000500008

Similar Items

Impact of intravesical Bacillus Calmette-Guérin and chemotherapy on the bladder microbiome in patients with non-muscle invasive bladder cancer
by: Christopher James, et al.
Published: (2023-04-01)

Efficacy of intravesical gemcitabine instillation compared with intravesical Bacillus Calmette-Guérin instillation for non-muscle invasive bladder cancer
by: Dong Ha Kim, et al.
Published: (2024-12-01)

Instillation Strategies for Non-Muscle-Invasive Bladder Cancer in the Bacillus Calmette-Guerin Shortage Era: A Simple Solution for BCG Discontinuation
by: Lin PT, et al.
Published: (2022-11-01)

Outcomes of intravesical Bacillus Calmette-Guerin in patients with non-muscle invasive bladder cancer: a retrospective study in Australia
by: Chamodi Pillippu Hewa, et al.
Published: (2024-02-01)

Bacillus Calmette-Guérin pneumonitis after intravesical instillation: Report of two cases and a review of the literature
by: Martina Spisarova, et al.
Published: (2024-06-01)

Intravesical bacillus Calmette–Guérin-induced myopathy presenting as rhabdomyolysis: a case report
by: Chae Hun Lee, et al.
Published: (2023-10-01)

Bacillus Calmette-Guerin (BCG) infections following intravesical BCG immunotherapy: a systematic review protocol
by: Roberta Monardo, et al.
Published: (2025-01-01)

Oncolytic and immunotherapeutic CG0070 adenovirus for high-risk bacillus calmette-guerin unresponsive bladder cancer
by: Evan Austin, et al.
Published: (2021-12-01)

Drug‐induced interstitial pneumonia after intravesical Bacillus Calmette‐Guerin administration for bladder cancer with scleroderma
by: Fumie Yoshioka, et al.
Published: (2023-03-01)

Late-onset granulomatous prostatitis following intravesical bacille Calmette-Guerin therapy: case report
by: Octavio Castillo Cádiz, et al.
Published: (2016-06-01)

Bacillus Calmette–Guérin in Immuno-Regulation of Alzheimer’s Disease
by: Benjamin Y. Klein, et al.
Published: (2022-06-01)

Intravesical Gemcitabine versus Intravesical Bacillus Calmette–Guérin for the Treatment of Non-Muscle Invasive Bladder Cancer: An Evaluation of Efficacy and Toxicity
by: Thiru Prasanna, et al.
Published: (2017-11-01)

Secondary Haemophagocytic Lymphohistiocytosis Syndrome (HLH) After Intravesical Instillation of Bacillus Calmette-Guérin (BCG): A Case Report and Review of the Literature
by: Konstantinos Manganas, et al.
Published: (2022-10-01)

Bacillus Calmette-Guérin Spondylodiscitis after Intravesical BCG Therapy: A Case Report
by: Akihito Kawai, et al.
Published: (2022-11-01)

Bladder Contracture – A Rare and Serious Side Effect of Intravesical Bacillus Calmette-Guérin Therapy
by: Cindy Garcia, et al.
Published: (2016-01-01)

Disseminated Bacillus Calmette–Guérin (BCG) infection and acute exacerbation of interstitial pneumonitis: an autopsy case report and literature review
by: Gen Shimizu, et al.
Published: (2020-09-01)

Successful treatment with low‐dose oral steroids for contracted bladder after intravesical instillation of Bacillus Calmette–Guérin
by: Akinobu Katami, et al.
Published: (2024-03-01)

Hyperthermia intravesical chemotherapy acts as a promising alternative to bacillus Calmette–Guérin instillation in non-muscle-invasive bladder cancer: a network meta-analysis
by: Na Zeng, et al.
Published: (2023-05-01)

Combined Application of Nivolumab and Intravesical Bacillus Calmette-Guérin Led to Acute-Onset Type 1 Diabetes
by: Koichi Fujiu, et al.
Published: (2019-06-01)

Penile lesion with inguinal adenopathy after intravesical Bacillus Calmette-Guerin instillation therapy
by: Guven Aslan, et al.
Published: (2013-01-01)

A case of disseminated M. bovis bacillus Calmette-Guérin (BCG) disease after one month of BCG bladder infusion therapy and analysis of 77 cases of suspected BCG infection in Japan, 2017–2022
by: Masashi Nishimura, et al.
Published: (2023-01-01)

Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023
by: Jiwoong Yu, et al.
Published: (2023-11-01)

Tuberculous Granuloma in the Scrotal Skin After Intravesical Bacillus Calmette-Guerin Therapy for Bladder Cancer: A Case Report
by: Hiroshi Shimura, et al.
Published: (2017-02-01)

Update on the Mechanism of Action of Intravesical BCG Therapy to Treat Non-Muscle-Invasive Bladder Cancer
by: Mohamad Abou Chakra, et al.
Published: (2024-08-01)

Afebrile tuberculous prostatic abscess with rectal fistula after intravesical Bacillus Calmette‐Guérin immunotherapy
by: Tatsuhiro Sawada, et al.
Published: (2025-01-01)

Saudi urologists’ treatment pattern for high-risk Bacillus Calmette–Guérin naïve and Bacillus Calmette–Guérin unresponsive nonmuscle invasive bladder cancer
by: Mohammad Alghafees, et al.
Published: (2025-01-01)

BCG and Alternative Therapies to BCG Therapy for Non-Muscle-Invasive Bladder Cancer
by: Sarah Lidagoster, et al.
Published: (2024-02-01)

Optimizing compliance and efficacy in intravesical BCG therapy for non-muscle invasive bladder cancer: tailored strategies and clinical outcomes
by: G. Shubhankar, et al.
Published: (2025-01-01)

Assessment of angiogenic factor, vascular endothelial growth factor, serum and urine level changes in superficial bladder tumor immunotherapy by intravesical Bacillus Calmette-Guerin
by: Kerigh Behzad, et al.
Published: (2010-01-01)

Intravescical instillation of Calmette-Guérin bacillus and COVID-19 risk
by: Ugo Fedeli, et al.
Published: (2021-02-01)

Incidental discovery of a case of renal tuberculoma after intravesical BCG treatment
by: Komi Hola Sikpa, et al.
Published: (2022-11-01)

Role of oral pentosan polysulfate in Bacillus Calmette–Guérin therapy in patients with non-muscle-invasive bladder cancer
by: Ho Yeon Lee, et al.
Published: (2022-09-01)

Complete response to intravesical gemcitabine in non‐muscle invasive bladder cancer patient after BCG failure: A case report and literature review
by: Fouad Nahhat, et al.
Published: (2022-09-01)

Intravesical adriamycin in the management of bladder tumours Enugu experience
by: Aloy E Aghaji, et al.
Published: (1996-01-01)

Early Experience With Pembrolizumab in Bacillus Calmette-Guérin Unresponsive Non–Muscle-Invasive Bladder Cancer
by: Chung Un Lee, et al.
Published: (2023-11-01)

Safety profiles of intravesical Bacillus Calmette-Guerin in bladder cancer
by: Yun Peng, et al.
Published: (2024-12-01)

A Phase 1b Clinical Study of Intravesical Photodynamic Therapy in Patients with Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer
by: Girish S. Kulkarni, et al.
Published: (2022-07-01)

Mycobacterium Bovis Spondylodiscitis: A Rare Complication of Intravesical Bacillus Calmette-Guérin Therapy
by: Frédéric Quatannens, et al.
Published: (2022-07-01)

Revitalizing Bacillus Calmette–Guérin Immunotherapy for Bladder Cancer: Nanotechnology and Bioengineering Approaches
by: Maoxin Lv, et al.
Published: (2024-08-01)

Multisystemic BCGitis: A rare complication of intravesical BCG immunotherapy for bladder cancer
by: Ana T. Vilares, MD, et al.
Published: (2022-07-01)